|
Volumn 94, Issue 3, 2011, Pages 389-396
|
Synthesis of a novel series of 2,3-disubstituted quinazolin-4(3H)-ones as a product of a nucleophilic attack at C(2) of the corresponding 4H-3,1-benzoxazin-4-one
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FTIR;
MASS SPECTROSCOPY;
NEW SERIES;
NOVEL SERIES;
NUCLEOPHILIC ATTACK;
QUINAZOLIN-4(3H)-ONES;
QUINAZOLINES;
SALT FORMATION;
SPECTRAL DATA;
STARTING MATERIALS;
MASS SPECTROMETRY;
SYNTHESIS (CHEMICAL);
2 [1 (ARYLMETHYLIDENE)PROPYL] 3 HYDROXYQUINAZOLIN 4;
2 [1 (ARYLMETHYLIDENE)PROPYL] 3 HYDROXYQUINAZOLIN 4(3H) ONE;
2 [1 [(1,3 BENZODIOXOL 5 YL)METHYLIDENE]PROPYL] 3 HYDROXYQUINAZOLIN 4(3H) ONE;
2 [1 [(3,4 DIMETHOXYPHENYL)METHYLIDENE]PROPYL] 3 HYDROXYQUINAZOLIN 4(3H) ONE;
2 [[4 OXO 2 PROPYLQUINAZOLIN 3(4H) YL]OXY]ACETIC ACID HYDRAZIDE;
2 [[4 OXO 2 PROPYLQUINAZOLIN 3(4H) YL]OXY]ACETOHYDRAZIDE;
2 PROPYL 4H 3,1 BENZOXAZIN 4 ONE;
2,3 DISUBSTITUTED QUINAZOLIN 4(3H) ONE;
3 (3 HYDROXYPHENYL) 2 PROPYLQUINAZOLIN 4(3H) ONE;
3 (ACETYLOXY) 2 PROPYLQUINAZOLIN 4(3H) ONE;
3 (ACETYLOXY)QUINAZOLIN 4(3H) ONE;
3 AMINO 2 PROPYLQUINAZOLIN 4(3H) ONE;
3 AMINOQUINAZOLIN 4(3H) ONE;
3 ETHYL[1,2,3] TRIAZOLO[5,1 B]QUINAZOLIN 9(1H) ONE;
3 HYDROXY 2 PROPYLQUINAZOLIN 4(3H) ONE;
3 HYDROXYQUINAZOLINONE;
4 [2 [1 (ARYLMETHYLIDENE)PROPYL] 4 OXOQUINAZOLIN 3(4H) YL]BENZOIC ACID;
4 [2 [1 [(1,3 BENZODIOXOL 5 YL)METHYLIDENE]PROPYL] 4 OXOQUINAZOLIN 3(4H) YL]BENZOIC ACID;
4 [2 [1 [(3,4 DIMETHOXYPHENYL)METHYLIDENE]PROPYL] 4 OXOQUINAZOLIN 3(4H) YL]BENZOIC ACID;
4 [2 [1 [[(4 DIMETHYLAMINO)PHENYL]METHYLIDENE]PROPYL] 4 OXOQUINAZOLIN 3(4H) YL]BENZOIC ACID;
4 [4 OXO 2 PROPYLQUINAZOLIN 3(4H) YL] N (THIAZOL 2 YL)BENZENESULFONAMIDE;
4 [4 OXO 2 PROPYLQUINAZOLIN 3(4H) YL]BENZENESULFONAMIDE;
4 [4 OXO 2 PROPYLQUINAZOLIN 3(4H) YL]BENZOIC ACID;
4H 3,1 BENZOXAZIN 4 ONE;
BENZOXAZINONE DERIVATIVE;
ETHYL 2 [[4 OXO 2 PROPYLQUINAZOLIN 3(4H) YL]OXY]ACETATE;
N (5 METHYLISOXAZOL 3 YL) 4 [4 OXO 2 PROPYLQUINAZOLIN 3(4H) YL]BENZENESULFONAMIDE;
QUINAZOLINE DERIVATIVE;
QUINAZOLINONE DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG STRUCTURE;
DRUG SYNTHESIS;
INFRARED SPECTROSCOPY;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
|
EID: 79952715877
PISSN: 0018019X
EISSN: 15222675
Source Type: Journal
DOI: 10.1002/hlca.201000230 Document Type: Article |
Times cited : (20)
|
References (18)
|